Jung Min Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jung Min Oh has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Young Chul Suh
Department of Plastic and Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
2 shared publications Byung Jun Kim
Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul, Republic of Korea
1 shared publicationDong Won Lee
Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
1 shared publicationHyung Min Hahn
Department of Plastic and Reconstructive Surgery, Ajou University Hospital, Suwon, Republic of Korea
1 shared publication- Jee Suk Chang
Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea
1 shared publication Jong Min Won
Department of Plastic and Reconstructive Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
1 shared publication
Latest Publications
- 29 January 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 46 (11) , 1272-1280
Efficacy of Stromal Vascular Fraction for Scar Prevention: A Multicenter, Double-Blinded, Randomized Controlled Trial
Background: Addressing postoperative scarring remains a significant challenge across all surgical procedures, often leading to long-term aesthetic deficits. Traditional methods for scar management have shown limited efficacy, prompting exploration into innovative approaches such as the application of stromal vascular fraction (SVF). Objectives: The efficacy of intraoperative SVF injection in modulating scar formation was assessed by evaluating postoperative scar quality in patients undergoing free tissue transfer. Methods: This multicenter, double-blinded, placebo-controlled, randomized study assessed the efficacy of intraoperative SVF injections in mitigating scar formation in patients undergoing free tissue transfer. A total of 45 patients were enrolled from 3 institutions, undergoing either breast reconstruction with abdominal flaps or soft tissue reconstruction with anterolateral thigh flaps. The donor site incision was split in half, with one side receiving SVF injections and the other saline injections, assigned randomly. Scar quality was evaluated using the Vancouver Scar Scale (VSS) and Patient Scar Assessment Questionnaire (PSAQ), along with objective measures of pigmentation using an analyzing device. Results: The primary analysis endpoint at 6 months after surgery showed a statistically significant improvement in VSS scores in the SVF group compared to the saline group. However, these differences were not maintained at the 9-month follow-up. PSAQ results indicated improved satisfaction with scar appearance at 6 and 9 months in the SVF group, despite no significant changes in erythema and melanin levels. Conclusions: Intraoperative SVF infection can improve postoperative scar appearance in patients undergoing free tissue transfer. This study supports further exploration of SVF as a potential tool for enhancing aesthetic outcomes in scar management. Level of Evidence: 2 (Therapeutic):
- 29 January 2026
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 46 (11) , 1272-1280
Efficacy of Stromal Vascular Fraction for Scar Prevention: A Multicenter, Double-Blinded, Randomized Controlled Trial
Background: Addressing postoperative scarring remains a significant challenge across all surgical procedures, often leading to long-term aesthetic deficits. Traditional methods for scar management have shown limited efficacy, prompting exploration into innovative approaches such as the application of stromal vascular fraction (SVF). Objectives: The efficacy of intraoperative SVF injection in modulating scar formation was assessed by evaluating postoperative scar quality in patients undergoing free tissue transfer. Methods: This multicenter, double-blinded, placebo-controlled, randomized study assessed the efficacy of intraoperative SVF injections in mitigating scar formation in patients undergoing free tissue transfer. A total of 45 patients were enrolled from 3 institutions, undergoing either breast reconstruction with abdominal flaps or soft tissue reconstruction with anterolateral thigh flaps. The donor site incision was split in half, with one side receiving SVF injections and the other saline injections, assigned randomly. Scar quality was evaluated using the Vancouver Scar Scale (VSS) and Patient Scar Assessment Questionnaire (PSAQ), along with objective measures of pigmentation using an analyzing device. Results: The primary analysis endpoint at 6 months after surgery showed a statistically significant improvement in VSS scores in the SVF group compared to the saline group. However, these differences were not maintained at the 9-month follow-up. PSAQ results indicated improved satisfaction with scar appearance at 6 and 9 months in the SVF group, despite no significant changes in erythema and melanin levels. Conclusions: Intraoperative SVF infection can improve postoperative scar appearance in patients undergoing free tissue transfer. This study supports further exploration of SVF as a potential tool for enhancing aesthetic outcomes in scar management. Level of Evidence: 2 (Therapeutic):
- 18 February 2025
- Published by Springer Nature in Breast Cancer
- Vol. 32 (3) , 520-528
Postoperative cholesterol changes as early predictors of breast cancer-related lymphedema: a retrospective cohort study
Background Early prediction and management are crucial for treating breast cancer-related lymphedema (BCRL), yet the risk factors remain poorly understood. This study aims to explore the relationship between postoperative changes in serum cholesterol levels and the development of lymphedema. Methods This retrospective study analyzed breast cancer patients who underwent surgery between March 2014 and March 2019. We assessed the development of lymphedema and changes in high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), and total cholesterol (TC) levels. Preoperative values were compared with those measured within 6 months post-surgery, and logistic regression models were used for statistical analysis. Results Among the 906 patients studied, 87 (9.6%) developed lymphedema, with a median onset of 15 months. An increase in serum HDL levels relative to baseline was associated with a reduced risk of lymphedema (odds ratio [OR] 0.94 per unit increase, 95% confidence interval [CI]: 0.92–0.95), even after adjusting for established factors such as body mass index, type of axillary surgery, number of lymph nodes removed, regional radiotherapy, and chemotherapy. In contrast, elevated serum TG levels were linked to a higher risk of lymphedema (OR 1.003 per unit increase, 95% CI: 1.001–1.006). No significant associations were found with changes in LDL or TC levels (p > 0.05). Conclusion Postoperative changes in HDL and TG levels are significantly associated with the risk of developing lymphedema, suggesting their potential role as early indicators. These results have important clinical implications for guiding follow-up care and early intervention strategies, although further validation is needed.
- 18 February 2025
- Published by Springer Nature in Breast Cancer
- Vol. 32 (3) , 520-528
Postoperative cholesterol changes as early predictors of breast cancer-related lymphedema: a retrospective cohort study
Background Early prediction and management are crucial for treating breast cancer-related lymphedema (BCRL), yet the risk factors remain poorly understood. This study aims to explore the relationship between postoperative changes in serum cholesterol levels and the development of lymphedema. Methods This retrospective study analyzed breast cancer patients who underwent surgery between March 2014 and March 2019. We assessed the development of lymphedema and changes in high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglyceride (TG), and total cholesterol (TC) levels. Preoperative values were compared with those measured within 6 months post-surgery, and logistic regression models were used for statistical analysis. Results Among the 906 patients studied, 87 (9.6%) developed lymphedema, with a median onset of 15 months. An increase in serum HDL levels relative to baseline was associated with a reduced risk of lymphedema (odds ratio [OR] 0.94 per unit increase, 95% confidence interval [CI]: 0.92–0.95), even after adjusting for established factors such as body mass index, type of axillary surgery, number of lymph nodes removed, regional radiotherapy, and chemotherapy. In contrast, elevated serum TG levels were linked to a higher risk of lymphedema (OR 1.003 per unit increase, 95% CI: 1.001–1.006). No significant associations were found with changes in LDL or TC levels (p > 0.05). Conclusion Postoperative changes in HDL and TG levels are significantly associated with the risk of developing lymphedema, suggesting their potential role as early indicators. These results have important clinical implications for guiding follow-up care and early intervention strategies, although further validation is needed.
- 13 September 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 86, 239-245
A bipedicled keystone perforator island flap: Pedicle division technique with enhanced advancement potential for chronic wound coverage
- 13 September 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 86, 239-245
A bipedicled keystone perforator island flap: Pedicle division technique with enhanced advancement potential for chronic wound coverage